Intelligence / Healthtech / De Novo Grants / Visby Medical, Inc.
Approvalsnovel device granted (FDA De Novo)28 Mar 2025
Visby Medical, Inc.
28 Mar 2025: Novel device granted (FDA De Novo) · Visby Medical Women's Sexual Health Test. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 28 Mar 2025
- Device
- Visby Medical Women's Sexual Health Test
- Specialty
- Microbiology
- Product Code
- SEA
- Country
- United States
- Location
- San Jose, CA
- Submitted
- 2024-05-13
- Reference
- DEN240020
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Visby Medical, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Microbiology
De Novo Grants
20 OctRoche Diagnosticsnovel device granted (FDA De Novo) · Elecsys HBsAg II quant II RxDxApprovals9 MayTeal Health, Inc.novel device granted (FDA De Novo) · Teal WandApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.